ASMB
Assembly Biosciences Inc
NASDAQ: ASMB · HEALTHCARE · BIOTECHNOLOGY
$20.86
+1.41% today
Updated 2026-10-29
Market cap
$409.04M
P/E ratio
19.32
P/S ratio
5.47x
EPS (TTM)
$1.04
Dividend yield
—
52W range
$20 – $40
Volume
0.3M
Assembly Biosciences Inc (ASMB) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$20.86
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$40.62
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -1.78% (capped 20%) · P/E: 19.32x (capped 25x) · Margin: -0.06%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.